During the Track Record Period, we provided contract manufacturing services to one biotechnology company based in Hefei, Anhui Province, for production of monoclonal antibody drug in compliance with GMP/cGMP standards.
Business · 第 386 页
As of March 31, 2024, the contractual obligations under the contract manufacturing service agreement had been fully fulfilled.
Financial Information · 第 428 页
We expect to devote our productive forces to our own drug candidates and products as our clinical trials progress and after our commencement of commercialization.
During the Track Record Period, to a relatively large extent, our revenue was generated from customers who were end customers, but whether our Group conducted business as a contractor or subcontractor did not have a material implication on our operations or standard of services.
Summary · 第 8 页
Accordingly, the capacities in which our Group obtained business or undertook a project (i.e. whether we act as a subcontractor or contractor) did not have a material implication on the operations or standard of services of our Group.
We sell offline to business customers who purchase our products and then sell to downstream businesses through their own online platforms or offline channels.
Business · 第 202 页
During the Track Record Period, revenue from our offline business customers represented 5.9%, 4.0% and 2.1% of the revenue of our Self-operation Business for the years ended 31 December 2020, 2021 and 2022, respectively.
Business · 第 203 页
With respect to offline allocation channels business, we generally allow a credit term of 30 to 90 days.